首頁
App 分析
ZoomRx
ZoomRx Vs. Sermo: Physician Network

ZoomRx 與 Sermo: Physician Network 使用情況與統計

ZoomRx is a survey platform that facilitates communication between doctors, patients, and pharmaceutical companies. The application enables patient/research organizations, pharmaceutical/biotech companies, and other survey sponsoring entities to collect information from "connected real-time panels" of patients, doctors, insurance providers, pharmacists and other stakeholders in the healthcare system. The surveys taken on ZoomRx will enhance the experience and lives of all parties involved in the health-care system by quickening the rate of information flow. The surveys on ZoomRx are designed as per guidelines issued by the Council of American Survey Research Organizations (CASRO). We adhere to the code of standards and ethics laid out by CASRO. If you have any questions on ZoomRx, please e-mail: info@zoomrx.com

Apple App Store
免費版
醫療

商店排名

- -

Sermo: Physician Network

Join Sermo – the #1 doctors-only global social platform! Sermo is free, private, secure, and open to all credentialed physicians. Nearly 800,000 doctors from 150 countries turn to Sermo to get paid for their expertise, seek second opinions, or unwind from a stressful day. Join today to: Discuss: share insights and expertise on clinical cases, practice management, healthcare policy or whatever else is on your mind. Plus, you can post anonymously for sensitive topics. Earn honoraria: get paid for your perspective! Sermo disburses more honoraria to doctors than any other organization in the world. Last year, Sermo paid out $16 million to doctors worldwide. Solve challenging patient cases: want a second opinion? How about hundreds of them? Connect and collaborate with other doctors in minutes. With thousands of challenging cases solved each year, this is medical crowdsourcing at its best. Rate drugs & read doctor reviews: access the first and only global peer-to-peer drug review system that’s for doctors, by doctors. Explore ratings and share your experiences to help improve treatment decisions globally.